The combination of oral-recombinant methioninase and azacitidine arrests a  chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model

ConclusionThis study suggests that o-rMETase-AZA combination has clinical potential for patients with chemoresistant osteosarcoma.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research